Related Experiment Video

Updated: Mar 21, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

900

Map4k4 Signaling Nodes in Metabolic and Cardiovascular Diseases

Joseph V Virbasius1, Michael P Czech1

  • 1Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.

Trends in Endocrinology and Metabolism: TEM
|May 11, 2016
PubMed

Insights

Mitogen-activated kinase kinase kinase kinase 4 (Map4k4) is a key regulator of glucose and cardiovascular health. Inhibiting Map4k4 shows promise in treating insulin resistance and atherosclerosis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Physiology

Background:

  • Mitogen-activated kinase kinase kinase kinase 4 (Map4k4) is increasingly recognized for its role in metabolic and cardiovascular regulation.
  • Previous research identified Map4k4 through siRNA screens and gene deletion studies.

Purpose of the Study:

  • To explore the emerging role of Map4k4 in glucose homeostasis and cardiovascular health.
  • To investigate the signaling pathways and upstream activators of Map4k4.

Main Methods:

  • Utilized gene ablation and kinase inhibition in mouse models.
  • Investigated Map4k4's involvement in insulin resistance and atherosclerosis.
  • Examined effects on signaling pathways like NFκB and the Hippo cascade.

Main Results:

  • Map4k4 gene ablation or inhibition reduced hyperglycemia and plaque formation in preclinical models.
  • Map4k4 influences multiple signaling pathways, including NFκB and small GTPase regulation.
  • Evidence suggests Map4k4's involvement in the Hippo cascade and cell dynamics.

Conclusions:

  • Map4k4 is a significant regulator of metabolic and vascular functions.
  • Further research is needed to define Map4k4's specific effectors and upstream activators.
  • Targeting Map4k4 presents a potential therapeutic strategy for metabolic and cardiovascular diseases.
Keywords:
Sterile 20 kinasesatherosclerosisdiabetesinsulin resistance

More Related Videos

Author Spotlight: Insights into Cardiometabolic Diseases with Subcutaneous Adipose Tissue Microvasculature Studies06:35

Author Spotlight: Insights into Cardiometabolic Diseases with Subcutaneous Adipose Tissue Microvasculature Studies

Published on: April 5, 2024

1.7K

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.7K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K